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Abstract
Background: Upon antigen exposure, cord blood derived T cells respond to ubiquitous environmental antigens by high
proliferation. To date it remains unclear whether these ‘‘excessive’’ responses relate to different regulatory properties of the
putative T regulatory cell (Treg) compartment or even expansion of the Treg compartment itself. Methods: Cord blood (.37
week of gestation) and peripheral blood (healthy controls) were obtained and different Treg cell subsets were isolated. The
suppressive potential of Treg populations after antigen exposure was evaluated via functional inhibition assays
([3H]thymidine incorporation assay and CFSE staining) with or without allergen stimulation. The frequency and markers of
CD4+CD25highFoxP3+ T cells were characterized by mRNA analysis and flow cytometry. Results: Cord blood derived
CD4+CD25high cells did not show substantial suppressor capacity upon TCR activation, in contrast to CD4+CD25high cells
freshly purified from adult blood. This could not be explained by a lower frequency of FoxP3+CD4+CD25highcells or FOXP3
mRNA expression. However, after antigen-specific stimulation in vitro, these cells showed strong proliferation and
expansion and gained potent suppressive properties. The efficiency of their suppressive capacity can be enhanced in the
presence of endotoxins. If T-cells were sorted according to their CD127 expression, a tiny subset of Treg cells
(CD4+CD25+CD127low) is highly suppressive even without prior antigen exposure. Conclusion: Cord blood harbors a very
small subset of CD4+CD25high Treg cells that requires antigen-stimulation to show expansion and become functional
suppressive Tregs.
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Introduction
Allergic disease in infancy has dramatically increased in the past
decades [1,2] and preventive strategies have become of rising
interest. It is assumed that immune dysregulation is an early event
which is measurable in the perinatal period, which is directly
linked to the maturation of the immune system [3,4,5]. There are
three time points to implement preventive strategies: before
sensitization, after sensitization (but before disease) and at the
onset of disease.
It has been considered a long time that the neonate is
immunologically naı¨ve and the development of specific immune
responses is restricted to the period after birth. However, in utero
exposure to environmental antigens has been documented in cord
blood [6,7,8,9] and amniotic fluid [10] which suggest that an
intrauterine sensitization to allergens is possible. An increased
proliferation and cytokine production of cord blood mononuclear
cells in response to nutritive allergens, when the mother has been
exposed, such as bovine beta-lactoglobulin (BLG) and aero-
allergens has been described [4,11,12,13]. The mechanisms that
regulate the development of allergen-specific immune responses in
the fetus and their relevance in protection or disease development
have not been completely understood. In general, a linkage to
intrauterine exposure with resulting T cell priming is assumed
[12,14,15,16].
Cord blood T cells are considered antigen-inexperienced cells of
naı¨ve phenotype (90% of CD3+ T cells express CD45RA+).
Despite this naı¨ve phenotype, responses to allergens do occur in
cord blood and seem to be more pronounced than in peripheral
blood [17]. Moreover, immune response of cord blood mononu-
clear cells differs markedly from peripheral blood mononuclear
cells later in life and is accompanied by apoptosis. Reasons for this
altered response to allergens in cord blood, could relate to a
functionally immature state of the putative regulatory T cell (Treg)
compartment or recent thymic emigrants [18]. Naturally occur-
ring subpopulation of Treg cells maintain self-tolerance and
prevent autoimmunity, inhibit rejection of transplants, prevent the
induction of anti-tumor responses, play a role in allergen tolerance
and regulate the immune response to infectious disease [19]. In
adults, the peripheral Treg cell compartment consists of thymus-
derived Treg cells [19] and inducible Treg cells [20]. Both subsets
of Treg cells have been primarily defined as CD4+ T cells that
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express high levels of CD25 (IL-2Ra) and FoxP3, a Forkhead box
P3 gene product. Functional suppressive studies in humans have
revealed that the brightest expression of CD25 (CD4+CD25high T
cells) possess inhibitory potential [21]. Treg cells possess a T cell
receptor (TCR) repertoire as broad as CD252 T cells [22] and it is
known that Tregs become suppressive after stimulation via the
TCR. Once activated, they suppress in an antigen non-specific
manner [23]. Similarly, FoxP3, a characteristic marker of
regulatory activity might also be transiently expressed by effector
T cells during activation. There is no highly specific Treg marker
defined so far [24,25]. Recent studies have demonstrated that
down regulation of CD127, a specific receptor for IL-7 can
distinguish Tregs from activated T cells [26,27,28].
In this study, we demonstrate that cord blood derived Treg
possess the ability to become highly suppressive upon antigen
exposure. Based on these results we hypothesize that early
exposure to innocuous antigens is vital to develop T cell tolerance
and is enhanced by innate immune response triggering environ-
mental factors.
Materials and Methods
Ethics statement
The protocol was approved by the local ethical committee of the
Medical University of Vienna and written informed consent was
obtained from all participants of the study (protocol no EK 619/
2006).
Cell culture
Human umbilical cord blood from randomly chosen full term
healthy infants (.37 weeks of gestation) was obtained by
venopuncture of the umbilical vein immediately after delivery
and placed in sterile sodium heparin tubes. Adult volunteers with
no history of food allergy and no sensitization (specific IgE
,0.35 kU/L, skin prick test negative) were used as controls.
Heparinized blood was drawn over Ficoll-Paque (Pharmacia,
Uppsala, Sweden). Mononuclear cells were isolated by density-
gradient centrifugation as described [29]. All allergens used were
tested for their endotoxin content present by using limulus
amoeboid lysate assay (Cambrex Bio Science, Walkersville, MD,
USA; limit of detection 0.035 EU/mL) [17], to get rid of possible
confounders. The following BLG preparations were used as
explained in detail in Eiwegger et al. (2008) [17]: BLG L-0130
(BLG [NP], Sigma Sciences, St Louis, MO, USA) were
contaminated with endotoxins (118 EU/mL, .90% BLG) and
LPS-free BLG (BLG [LF], PSDI-2400, produced from bovine
whey protein isolate, Arla Food, Arhus, Denmark, .95% BLG]
contained 0.96 EU. Purified, endotoxin-free Ara h 1, was
provided by Dr E. N. Mills, (IFR Norwich, UK, ,0.035 EU/
mL). All assays were performed in serum-free Ultra Culture
Medium (UCC, Biowhittaker, Walkersville, MD, USA) supple-
mented with 2 mM L-glutamine and 170 mg/L gentamycine-
sulphate (Sigma Sciences) in 96-well round-bottom microplates in
triplicates.
In vitro proliferation assays
Proliferation was assessed via [3H]-thymidine incorporation assay
and CFSE staining. The cells were cultured for 3 and 7 days and
pulsed with [3H]-thymidine ([3H]TdR; 0.5 mCi [0.0185 MBq] per
well; Amersham, U.K.) for the last 16 h of the culture. According to
literature, a Stimulation index (SI).2 was considered positive [30].
Cells were cultured either alone (control) or stimulated for 72 hours
with 250 ng/mL plate-bound anti-CD3 (UCTH1 clone, Dako,
Glostrup, Denmark) or 7 days with b-lactoglobulin (BLG [NP] or
BLG [LF]).
Purification of regulatory T cells. The regulatory T cell
subset (CD4+CD25+ cells) was generated via magnetic cell sorting
(MACSH;Miltenyi Biotec, Auburn, CA, USA). CD4 T cells were
negatively enriched using Miltenyi CD4 T cell isolation kit II
(Miltenyi Biotec) according to the manufacturer’s instruction. The
CD25+ fraction was collected by eluting the cells two times through
magnetic separation (MS) column to further enrich CD25high cells.
The CD4+CD252 fraction was additionally purified over a LD
column.
To investigate the relevance of CD127low cells on the inhibitory
capacity, CD4+ cells were negatively sorted via MACSH as described
above and the respective subpopulations were isolated via a FACS
sorter (Becton Dickinson, San Jose´, CA, USA; FACSAriaTM; Purity
.99.5%).
Inhibition assay. To assess the suppressive capacity of
unprimed CD4+CD25+ T cells, increasing numbers of
CD4+CD25+ T cells (2.56103–2.56104 cells/well) were co-
cultured with CD4+CD252 T cells (2.56104 cells/well). Cells
were stimulated with 250 ng/mL plate-bound anti-CD3 (UCTH1
clone, Dako) or BLG [NP] [50 mg/mL] in the presence of irradiated
autologous CBMCs or PBMCs (56104 cells/well; 3,000 rad). The
cells were cultured for 3 or 6 days and pulsed with [3H]-thymidine
for the last 16 h of the culture. The inhibitory potential is expressed
as relative proliferation compared to the CD4+CD252 cells.
Priming assay. CD4+CD252 T cells were MACS-sorted
and frozen on day 0. CBMCs were first stimulated for 6 days in the
presence of LPS-free-BLG [LF] [50 mg/mL] or BLG [NP]
([50 mg/mL]; in a 25 cm2 culture flask (BD Falcon).
Flow Cytometric analysis
Four color fluorescence staining was performed using anti-CD3
(PerCP, APC), anti-CD8 (PE, PerCP), anti-CD25 (APC), anti-
CD45RA (PE), anti-CD45RO (PE, APC), anti-CD45RB (PE),
anti-CD69 (PE), anti-CD103 (PE), anti-CD127 (PE), anti-HLA-
DR (PE) and anti-CTLA-4 (PE), as well as regarding isotype
controls (all from Becton Dickinson) and anti-CD25 (PE) (Miltenyi
Biotec, Bergisch Gladbach), CD127 (APC) (R&D, McKinley
Place, MN, USA), GARP (Alexis Corporation, Farmingdale, NY,
USA) and a PE anti-mouse/rat FoxP3 Staining Set (e-Biosciences,
San Diego, CA) and were used according to the manufacturer’s
instructions.
To define dividing cells, purified cell fractions were stained with
carboxyfluorescein diacetate succinimidyl ester (CFSE, Sigma-
Aldrich) as explained recently [17].
Cord blood derived CD4+CD25+ and CD4+CD252 cells were
isolated with the Treg isolation kit (Miltenyi Biotec) stained with
CFSE according to the manufacturer’s protocol. CD4+CD25+
cells alone and CD4+CD252 cells alone as well as a combination
of CD4+CD25+ and CD4+CD252 where always only one
population was CFSE stained, was incubated with different stimuli
(BLG [NP], BLG [LF]) and medium control for 7 days in a CO2
incubator. On day 7, cells were analyzed via a cytometer and
proliferation was measured.
All cytometric measurements were performed with a FACS
Calibur and evaluated with CellQuest software (Becton Dick-
inson).
PCR
Total RNA was extracted from freshly isolated CBMCs or
PBMCs using the GenElute Mammalian Total RNA Miniprep
Kit (Sigma Sciences). The RNA was reverse-transcribed applying
‘‘iScript cDNA Synthesis Kit’’ from Bio-Rad (Hercules, USA)
Cord Blood Derived Tregs Become Functional
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according to the manufacturer’s instructions. Real-time polymer-
ase chain reaction (RT-PCR) amplification was performed in
triplicate on CFX96 (Bio-Rad) using a cycling profile of 2 min at
95uC followed by a total of 40 temperature cycles with 15 sec at
95uC and 1 min at 60uC. All experiments were run in triplicates
with the same thermal-cycling parameters. Expression of FOXP3,
IL-10, TGF-b, GARP (FOXP3 FW 59-ATG GCC CAG CGG
ATG AG-39, RV 59- GAA ACA GCA CAT TCC CAG AGT TC
-39, IL10 FW 59- GTG ATG CCC CAA GCT GAG A -39, RV
59- CAC GGC CTT GCT CTT GTT TT -39, GARP FW 59-
GCC CTG TAA GAT GGT GGA CAA G -39, RV 59-CAG
ATA GAT CAA GGG TCT CAG TGT CT -39 and r18S
(housekeeping gene) were measured using QuantiTect primers
(Qiagen, Hilden, Germany). Melting-curve analysis was used to
assess the specificity of the assay. To compare expression of genes
between patient groups the calculation was as follows: The sample
with the lowest amount of the respective gene was set as internal
standard to one and relative expression was calculated as follows:
22(DCt sample of interest2DCt lowest sample).
Statistical analysis
Statistical analysis was performed with SPSS software (version
16 for Windows; SPSS, Inc, Chicago, III). Groups were compared
using the Mann-Whitney U test for (non-parametric) unpaired
responses. The Wilcoxon matched-pairs signed-rank test was used
to examine paired data. When Gaussian distribution was given,
the Student t-test for independent samples or matched pairs t-test
was performed. A p-value of less than 0.05 was considered
statistically significant for all analyses.
Results
Comparable Treg-related transcription factor and marker
expression in cord and peripheral blood
Cord blood varies from PB due to a differential surface
expression. In CB, about 90%68.5 (Mean6SD) T helper cells are
CD45RA+ whereas only 54%63.5 of the PB derived T cells show
a naı¨ve phenotype. In addition, the CD127 pattern is also different
in the PB compartment. A higher amount of CD127+ T cells
(6.5%61.6 vs 2.762.4) but a similar amount of CD127lowCD25+
T cells was observed (6.361.4 vs 8.261.8); Figure 1A).
Moreover, FoxP3-expression, the most important transcription
factor in Tregs has been examined by intracellular staining and
flow cytometry. Gating strategy was performed according to
several published approaches but no significant differences could
be detected (supporting information, Figure S1).
Messenger RNA expression of a panel of Treg-associated
transcription factors and Treg-associated cytokines was measured in
the CD25 positive and negative fraction in cord blood and peripheral
blood. GARP, RUNX1, RUNX3, TGF-b, IL-10 mRNAs were
determined. There was a strong up-regulation of these markers in the
CD25 positive fraction, however there were no significant differences
with regard to the relative up-regulation of these Treg-specific
markers between cord blood and peripheral blood (Figure 1B).
Figure 1. Comparable Treg-related transcription factor and marker expression in CB and PB on day 0. (A) Cord and peripheral blood
derived mononuclear cells were analyzed via flow cytometry on day 0 without prior stimulation. Surface and intracellular staining was performed and
one out of three representative experiments is shown. (B) Real-time PCR analysis was performed to quantify the gene expression of Treg-related
markers (FOXP3, GARP, TGF-b, RUNX 1, RUNX 3, and IL-10). Results are representative for three independent experiments showing the normalized
expression. CD4+CD252 T cells are displayed with white and CD4+CD25+ T cells with black squares.
doi:10.1371/journal.pone.0029355.g001
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Increased T cell proliferative responses to BLG in cord
blood is due to a significantly reduced suppressive
capacity of CD4+CD25+ cells
Higher T cell proliferation has been observed in cord blood-
derived mononuclear cells compared to peripheral blood-derived
cells in response to one of the major milk allergens BLG [17]. To
assess whether the reasons for this altered responses in cord blood
could be explained by differences in regulatory T cells in cord
blood, the inhibitory capacity of CB derived Tregs were compared
to those from adult blood. The unprimed PB-derived CD4+CD25+
fraction from adults (Figure 2A) and children under the age of
four (supporting information, Figure S2) possessed dose-depen-
dent inhibitory properties, whereas CB-derived CD4+CD25+ T-
cells were hypoproliferative but significantly less potent.
The CD25+CD127low compartment of CD4+ T cells
harbors a regulatory T cell subset with limited net
suppressive effect
No or low CD127 expression has been described to be an
excellent marker for Treg characterization [31]. Recently, the
suppressive capacity of CD4+CD25+CD127low/2 Tregs in cord
blood has been linked to the development of food allergy [32]. The
CD127low fraction was purified by means of FACS-sorting from
the CD25high and CD25med fraction to investigate the suppressive
capacity of low CD127 expressing Treg cells in cord blood.
Subsets with low CD127 expression (CD4+CD25highCD127low
(Figure 2B; F1) and CD4+CD25intCD127low (Figure 2B; F2)
possessed suppressive potential, whereas the CD4+CD25intCD127high
subset (Figure 2B; F3) was associated with proliferation upon BLG
stimulation. The same effect has been observed upon stimulation
with the allergens Ara h 1 and OVA (supporting information,
Figure S3). TGF-b or IL-10 mRNA levels were not substantially
up-regulated whereas FOXP3 was increased in the respective
subsets (Figure 2C).
Cord blood-derived CD4+CD25+ T cells become highly
suppressive
Based on the fact, that tolerance development after birth has to
take place within a short period of time the role of environmental
antigens to prime this procedure was investigated [33]. CBMCs
were exposed for six days to BLG in the presence or absence of
LPS (Figure 3A). CD4+CD25+ cells were isolated and their
suppressive potential on anti-CD3- and BLG-induced proliferation
of autologous CD4+CD252 cells was investigated, and an
inhibition of 53% and 83%, respectively, was observed. The same
regulatory subset that did not show any inhibitory function in the
experiments on day 0 gained inhibitory potential after stimulation
with BLG. FOXP3 and GARP expression was strongly up
regulated in Tregs when compared to CD4+CD252 T cells. BLG
exposed cells displayed relatively higher amounts FOXP3 and
GARP. The expression pattern of RUNX 1 and RUNX 3,
however, is less clear. A trend towards a higher expression of
RUNX 1 and RUNX 3 is observed in cord blood mononuclear
cells (Figure 3B).
Evidence for activation and expansion of Tregs in cord
blood upon exposure to allergens
In vitro, allergen stimulated CBMC displayed potent suppressive
functions. Thus, it was of interest to elucidate whether this is due
to the switch and generation of new or expansion of pre-existing
antigen-specific regulatory T cells. Initially, CD4+CD25+ and
CD4+CD252 from CB were MACS-sorted, CFSE-labeled on day
0 and then were stimulated with BLG (middle), or BLG+LPS
(right) (Figure 4A). As anticipated the CD4+CD25+ fraction was
hypoproliferative as compared to the CD4+CD252 fraction.
However, in cord blood the CD252 fraction down regulated
CD4 as descried in apoptotic, cord blood derived CD4+ T-cells.
Thereafter, cells were cultured with the allergen and sorted
according to their CFSE intensity and CD25 expression on day 6
as indicated in Figure S4 (supporting information). Again,
inhibition assays were performed (Figure 4B). Importantly both,
the dividing and the non-dividing fractions emerging from the
CD4+CD25+ cell population, possessed equal suppressive capacity
after the allergen exposure
Discussion
The allergen specific immune response in CB is poorly
understood and specificity of allergen proliferation regarding the
detection of clinically relevant effector T cells is still questioned.
We could recently demonstrate that CB derived mononuclear cells
are more sensitive than mononuclear cells from adults in terms of
proliferative responses to both, purified allergens and allergens
plus endotoxin [17,34]. As human CB mainly harbors naı¨ve T
cells they represent a perfect model system for a naı¨ve human
system to assess the impact of allergens.
Allergen-specific proliferative responses in CB vs. adult blood
cells were significantly higher quantitatively and qualitatively
(supporting information, Figure S5). We provide evidence that
freshly isolated CB derived Tregs share many phenotypic
characteristics with their PB derived counterpart. They lack
however potent suppression of CD4+CD252 T cells, in contrast
to PB derived Tregs. This is observed both for TCR-cross-linking
and allergen-specific stimulation. Although our finding are
consistent with findings of many different groups
[18,35,36,37,38,39] the herein provided data is focusing on the
antigen specific subsets. Although some studies demonstrated a
strong suppressive potential of CB derived Tregs, at a closer look
this was obtained after pre-activation with polyclonal stimuli
[40,41]. This was also observed in our hands upon expansion of
CD4+CD25+ T cells via CD3CD28 beads in the presence of IL-2.
The reasons for this reduced functionality remains to be
speculative. Several points can be ruled out by our experiments.
Figure 2. CB-derived CD4+CD25+ T cells are deficient with regard to their regulatory function harboring a subset with limited net
suppressive effects. (A) Specificity of proliferation to BLG and BLG+LPS is displayed via CFSE labeling experiments. (B) Inhibition experiments were
performed using and increasing amount of MACS-sorted CD4+CD25+ T cells to the CD4+CD252 fraction in presence of irradiated APCs. The inhibitory
potential is expressed as relative proliferation compared to the CD4+CD252 cells. Graphs indicate the means of 5–8 independent experiments with
means +/2 SEM. Wilcoxon sign rank test was applied. P-values of less than 0.05 were considered significant. (C) CBMCs were separated via FACS on
day 0 according to their CD25 and CD127 expression. Four subgroups (CD4+CD25highCD127low (F1), CD4+CD25intermediateCD127low (F2),
CD4+CD25intermediateCD127high (F3), and CD4+CD252 T cells (CD252)) were obtained. An inhibition assay was performed with the first three
fractions using the CD4+CD252 T cells as effector cells. The inhibitory potential is expressed as relative proliferation compared to the CD4+CD252
subgroup. Graphs indicate the means of 4 independent experiments and SEM. (D) Real-time PCR analysis was performed to analyze the FOXP3, TGF-
b, and IL-10 expression for further examination of the four fractions. Data represents three independent experiments showing the normalized
expression of means +/2 SEM.
doi:10.1371/journal.pone.0029355.g002
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First, no significantly lower FoxP3+CD4+CD25high T cells numbers
are observed in cord blood. Second, the regulatory T cell fraction
CD4+CD25+CD127low possessed inhibitory capacity without pre-
activation as indicated but does not explain the cord blood related
differences. Third, CB and PB derived mononuclear cells mainly
differ in their percentage of naı¨ve T cells that express a
CD45RA+CD45RO2CD62Lbright phenotype whereas the adult
CD4+ T cells exhibit a memory phenotype (CD45RA2CD45RO+)
[21,42]. So it is conceivable that freshly isolated CB CD4+CD25+ T
cells are less suppressive due to their phenotypic immaturity.
Based on numerous studies performed with Tregs, it is possible
that a specific subset of naı¨ve CB CD4+CD252 can be ‘‘educated’’
Figure 4. Evidence for activation and expansion of Tregs in cord blood upon exposure to allergens. (A) CD4+CD25+ and CD4+CD252 T
cells were isolated via MACS on day 0, stained with CFSE and stimulated for 7 days in the presence of medium alone (left), BLG (middle), and BLG+LPS
(right). Cells were gated on CD3+CD4+ cells and proliferation was measured by rating the CFSE distribution. For every stimulus a scatter dot-plot (left)
and a histogram (right) is displayed. Data represents one out of four independent experiments. Cord blood derived CD4+CD25+ T cells do proliferate
upon BLG+LPS stimulation (22.65%), and to a lesser extent when stimulated with BLG (3.37%). In contrast, CD4+CD252 T cells strongly proliferate
upon stimulation with BLG+LPS (64.79%). (B) After a six-day priming with BLG, cells were FACS sorted according to their CFSE intensity and CD25
expression. Inhibition assays were performed with CFSElowCD25+ and CFSEhighCD25+ T cells representing the regulatory fraction and with antigen-
inexperienced CD4+CD252 in the presence of BLG. The relative inhibition and the counts per minute are displayed.
doi:10.1371/journal.pone.0029355.g004
Figure 3. Upon primingwith BLG, cord blood derived CD4+CD25+ T cells become highly suppressive. (A) Cord blood-derivedmononuclear
cells were co-cultured for 6 days with the antigen BLG. At day six CD4+CD25+ T cells were MACS-sorted and an inhibition assay was performed with the
CD4+CD252 (frozen on day 0, without prior antigen exposure) and stimulated with a-CD3 or BLG. The inhibitory potential is expressed as relative
proliferation compared to the CD4+CD252 cells. Results are representative for 6–9 independent experiments. Wilcoxon signed rank test was applied. P-
values of less than 0.05 were considered significant (*); p,0.005 (**); p,0.001 (***). (B) Real-time PCR analysis was performed to quantify the gene
expression of Treg-related markers (FOXP3, GARP, RUNX 1, and RUNX 3) after allergen exposure. Results are representative for three independent
experiments showing the normalized expression. CD4+CD252 T cells are displayed with white and CD4+CD25+ T cells with black squares.
doi:10.1371/journal.pone.0029355.g003
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and expanded to become suppressive CD25+FoxP3+ Tregs as also
suggested by Zelenay et al [43]. Our study demonstrates the
inhibitory potential of the regulatory T cell subset after stimulation
in vitro with allergens. The newly generated Tregs were highly
suppressive in an antigen-nonspecific manner. This corresponds
with the observation in other studies as CD25+ Tregs need antigen
specific stimulation via the TCR to become suppressive, but once
activated, they suppress antigen-unspecifically [23]. Thornton et
al. (2004) also posted that the CD4highCD25+ population is a
surviving population in cord blood. We focused in particular on
these populations.
Based on our findings, we hypothesize that endotoxins and also
allergen contact directly after birth are pivotal to gain allergen
specific suppressive regulatory functions upon re-exposure result-
ing in tolerance to environmental antigens. This is in line with shift
in the paradigm from allergen avoidance direction exposure in
order to achieve tolerance. In fact no association between the level
of environmental exposure and the extent of allergen-induced
proliferation could be found [44]. The exposure is also not related
to an increased sensitization [45]. The mechanism to acquire
tolerance is not clear yet but regarding our mRNA data we can say
that it cannot be explained due to TGF-b or IL-10 related effects.
The extent of TGF-b or IL-10 up-regulation however is by far less
than for FOXP3.
In summary, we have shown that cord blood derived Tregs
need to be pre-activated before becoming highly suppressive.
Regulatory subsets are generated by both, functional maturation
and clonal expansion.
Supporting Information
Figure S1 FoxP3 expression was analyzed comparing
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and the standard error of the mean. Mann Whitney U-Test was
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